Ocular sets IPO range

Ocular Therapeutix Inc. (Bedford, Mass.) amended its IPO on NASDAQ and now plans to sell 5 million shares at $14-$16. At the $15 midpoint, the company would raise $75 million and be valued at $308.5 m...